Petri dish being used in research and development
Petri dish being used in research and development

Driving Innovation

Quality control Laboratory

Deeply committed to innovation, we invest 10% of our turnover each year in R&D.

 

Our aim is to meet the needs of our customers while supporting our global vision around the One Health approach.

We innovate not only in animal health products, but also in industrial production, equipping our sites with smart technologies. We develop solutions that meet the specific needs of each species, paying particular attention to their well-being, behavior, and infectious diseases.

Professionals working on research and innovation within the U.S. are focused on improving the health and wellbeing of both farm animals and pets. ​

 

 

Dedicated Innovation Centers

 

 

Woman working in Ceva's R&D Lab

Research and Development – Lenexa, Kansas​

The Lenexa Campus R&D teams operations are centered in an 18,000 square feet of BSL-2 (biosafety level 2) laboratory space. Unique teams conduct both pharmaceutical and biological research. ​

Ceva's decentralized structure allows each team great autonomy to develop their own ideas, but still fosters the sharing of ideas and innovation around the world​

​

Genomic Innovations Center – Shawnee, Kansas​

The Genomic Innovations Center opened in 2024. This location houses the R&D Genomic Platforms/SRV and Next Generation Sequencing teams, both important to Ceva for field surveillance of emerging and evolving diseases leading to vaccine development. The newly renovated GIC consists of two laboratories underlining the company’s ongoing commitment to next generation vaccine development.  ​

​

Ceva Biotechnology Campus – Philadelphia, Pennsylvania​

In early 2024, Ceva announced the strategic acquisition of Scout Bio, Inc. a pioneer in biotechnology focused on cutting-edge therapies for pets. The move represents a significant leap in innovation for Ceva, unlocking access to key advancements including a pipeline of monoclonal antibodies and gene therapy developments to address chronic diseases in pets. With this strategic acquisition Ceva expanded its global biotechnology activities, fostering a future characterized by the acceleration of biotherapeutic innovation.​

We have a responsibility to use our veterinary expertise for the good of all animals and our society.

Group of chickens

Poultry

At the core of our action is the prevention of diseases, recognizing that maintaining the health of animals not only enhances their quality of life but also helps production resilience, all while safeguarding the environment. This creates a triple benefit for farmers, their animals, and consumers alike.
a child hugging a husky dog in a forest

Companion animals

The seamless bond between humans and their animals can be affected by behavioral challenges resulting from environmental or health factors. In our commitment to nurturing the unique connections between pet owners and their companions, Ceva invests its efforts in three pivotal domains: behavior, parasitology, and veterinary specialties.
Formerly ScoutBio, Ceva's research team working on monoclonal antibodies and gene therapy n Philadelphia, Pennsylvania

Driving Innovation

Ceva advances global biotechnological innovation with the acquisition of Scout Bio, a leader in pet biotherapies.

This strategic move brings key assets, including monoclonal antibodies and gene therapy solutions, accelerating Ceva’s development of cutting-edge treatments for chronic diseases.
Woman scientist working on research project

Equipment & Smart Solutions

At Ceva, innovation is embedded in our performance.

Not only do we offer innovative vaccines, we pair them with technology to support their use. Success starts in the hatchery with our Genesys™ gender sorting equipment. It’s followed up with vaccination equipment and data support to ensure vaccines are optimally administered.
Ceva Wildlife Research Fund
White logo Ceva

Ceva Wildlife Research Fund, empowering science to protect vulnerable animals.

Learn more..